Lido Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.5M Sell
126,022
-11,679
-8% -$1.25M 0.05% 198
2025
Q1
$13.9M Buy
137,701
+2,954
+2% +$298K 0.06% 184
2024
Q4
$12M Buy
134,747
+13,018
+11% +$1.16M 0.05% 188
2024
Q3
$10.2M Buy
121,729
+4,394
+4% +$368K 0.05% 186
2024
Q2
$9.04M Buy
117,335
+101,587
+645% +$7.82M 0.05% 183
2024
Q1
$1.08M Buy
15,748
+391
+3% +$26.8K 0.01% 574
2023
Q4
$888K Buy
15,357
+2,091
+16% +$121K 0.01% 601
2023
Q3
$700K Buy
13,266
+3,669
+38% +$194K 0.01% 585
2023
Q2
$519K Buy
9,597
+2,519
+36% +$136K ﹤0.01% 654
2023
Q1
$354K Sell
7,078
-2,398
-25% -$120K ﹤0.01% 748
2022
Q4
$438K Buy
9,476
+83
+0.9% +$3.84K 0.01% 571
2022
Q3
$363K Buy
9,393
+218
+2% +$8.43K ﹤0.01% 581
2022
Q2
$341K Sell
9,175
-154
-2% -$5.72K ﹤0.01% 590
2022
Q1
$413K Buy
9,329
+2,235
+32% +$98.9K ﹤0.01% 588
2021
Q4
$301K Buy
7,094
+227
+3% +$9.63K ﹤0.01% 710
2021
Q3
$297K Buy
6,867
+509
+8% +$22K ﹤0.01% 655
2021
Q2
$272K Buy
6,358
+798
+14% +$34.1K ﹤0.01% 652
2021
Q1
$215K Sell
5,560
-12
-0.2% -$464 ﹤0.01% 689
2020
Q4
$200K Sell
5,572
-2,866
-34% -$103K ﹤0.01% 678
2020
Q3
$322K Buy
8,438
+47
+0.6% +$1.79K 0.01% 409
2020
Q2
$295K Buy
8,391
+1,976
+31% +$69.5K 0.01% 393
2020
Q1
$209K Buy
6,415
+227
+4% +$7.4K 0.01% 446
2019
Q4
$280K Buy
6,188
+522
+9% +$23.6K 0.01% 466
2019
Q3
$231K Sell
5,666
-839
-13% -$34.2K 0.01% 461
2019
Q2
$279K Buy
+6,505
New +$279K 0.02% 400